NCT03630536

TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative

CompletedOBSERVATIONAL

Trial Details

Start: 2018-08-12Est. Completion: 2026-03-30

Enrollment target: 28 participants

Locations

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Other microbiome trials you might be interested in

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate RiskPhase 2Recruiting

Metastatic Clear Cell Renal Cell Carcinoma

The purpose of this study is to evaluate the safety and feasibility of a treatment holiday strategy directed by CD70-tar…

Nanjing, ChinaEst. completion Aug 10, 2028

View Trial →

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)Phase 2Recruiting

Metastatic Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Renal Cell Cancer AJCC v8TFE3-Rearranged Renal Cell CarcinomaUnresectable Renal Cell Carcinoma

This phase II trial studies how well axitinib and nivolumab work in treating patients with TFE/translocation renal cell …

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.